Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-16008207Phase 4Recruiting
Phase 4, open-label, single-arm trial of allicin in hepatic fibrosis and Cirrhosis, sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoints: Hepatic parameters, Blood coagulation analysis and 3 more. Started Feb 2010; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-16008207.